Psoriasis Market Commodities, High Growth Opportunities, Segmentation, Market Trends By 2024-2033|AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation

The Psoriasis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Psoriasis Market:

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

According to The Business Research Company’s Psoriasis Global Market Report 2024, The psoriasis market size has grown rapidly in recent years. It will grow from $23.87 billion in 2023 to $26.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to epidemiology, patient awareness and education, healthcare infrastructure and access.

The psoriasis market size is expected to see rapid growth in the next few years. It will grow to $39.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to regulatory approvals, patient preferences, aging population, increased awareness, introduction of novel therapies. Major trends in the forecast period include advancements in research and development, biologics and targeted therapies, oral small molecule therapies, personalized medicine, telemedicine and digital health, patient-centric care, biosimilars, artificial intelligence and machine learning.

The rise in the prevalence of psoriasis patients is driving the Psoriasis market. Psoriasis is caused due to immune system, genetics, and environment. The rise in psoriasis patients in the past few years can be mainly attributed to climate change, stress, and an unhealthy lifestyle. According to the World Psoriasis Day consortium, 125 million people globally – 2 to 3% of the total population have psoriasis. Therefore, the rise in the prevalence of psoriasis patients is expected to propel the growth of the psoriasis over forecast period.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=2414&type=smp

The psoriasis market covered in this report is segmented –

1) By Drug class: Interleukin Inhibitors; Corticosteroids; Anti-Inflammatory; Tumor Necrosis Factor Inhibitor

2) By Drug Types: Small molecules; Biologics

3) By Disease Indication: Plaque Psoriasis; Nail Psoriasis; Guttate Psoriasis; Pustular Psoriasis; Erythrodermic Psoriasis

4) By Route Of Administration: Oral; Tropical; Injectable

5) By Distribution Channel: Hospitals; Retail Pharmacies; E-Commerce

The psoriasis market report table of contents includes: